RX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay on automated analysers. Catalogue Number: CYS4004
FDA Recall Z-2425-2024 · Posted 2024-07-24
Advertisement
Recalling FirmRandox Laboratories Ltd.
Recall StatusOpen, Classified
Product CodeNDY
Date Initiated2024-06-07
Product Quantity115 kits
Reason for Recall
Cystatin C Reagent marketed without a 510 (k)
Firm Action
Randox issued Medical Deice Correction Letter (REC748) to end-users on 6/7/24 via email. Letter states reason for recall, health risk and action to take:
Randox are discontinuing distribution of Cystatin C Reagent, Catalogue Number CYS4004 to and within United States of America and Puerto Rico, until further notice.
NB The product is still performing as expected and there are no safety concerns with the functionality of the devices. This notification is strictly regulatory, as the affected devices require a new FDA Licence
Action to be taken:
Transmission of Customer Notification: Send a copy of the notification to all affected customers and to those who need to be aware within the organisation.
Complete and return the response form (12187-QA) to [email protected] within five working days.
If you have any questions or concerns, please contact Randox Technical Services
Root Cause
No Marketing Application
Distribution Pattern
US Nationwide distribution in the states of AL, CA, GA, NY.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement